Special News
Greenstone Biosciences is a proud sponsor of the 2024 Stanford Drug Discovery Symposium that was held at Stanford between April 29-30.
Greenstone Biosciences is a proud sponsor of the 2023 Stanford Drug Discovery Symposium that was held at Stanford between April 24-25.
Learn about the diversity of cells banked at the Greenstone Biosciences biobank here. We are continuously expanding, and should you have any questions, please feel free to inquire by sending us an email at info@greenstonebio.com.
Below is a link to the audio-visual media for this poster.
Greenstone Biosciences is excited to announce that our distinguished co-founder, Dr. Joseph C. Wu, has assumed the prestigious role of President of the American Heart Association. A pioneering luminary in cardiovascular research, Dr. Wu’s advancements have propelled the field towards new horizons.
Over nearly 20 years at Stanford University, Dr. Wu has made significant advances in the field of cardiovascular medicine. His lab has developed techniques to turn a person’s blood into replicas of the heart cells they had at birth. Dr. Wu is also a pioneer in the use of regenerative stem cells to repair damaged heart tissue. This innovation has opened the door for researchers worldwide to study the development of heart disease and pinpoint new therapeutic targets, heralding a quantum leap in our understanding and treatment of heart disease.
At Greenstone Biosciences, we laud Dr. Wu’s commitment to the principles of diversity and inclusion. His endeavors to foster an inclusive environment within the scientific community, promoting the participation and recognition of individuals from all backgrounds, echo our own ethos and vision.
We take immense pride in Dr. Wu’s elevation to the presidency of the American Heart Association. Under his presidency, we anticipate a wealth of groundbreaking research and significant strides in patient care.
We want to congratulate our co-founder Joseph C. Wu, as well as Juan G. Santiago, and Nick McKeown of Stanford University, who were among the distinguished academic inventors inducted into the Class of 2022 of the National Academy of Inventors. They are among the 24 members of NAI from Stanford University.
Greenstone Biosciences would like to welcome Axel Brunger of Stanford University to its Scientific Advisory Board. His expertise and invaluable insights on Structural Biology and Molecular Dynamics will greatly facilitate and accelerate Greenstone Biosciences’ Drug Discovery programs.
Axel Brunger is interested in the molecular mechanisms of synaptic vesicle fusion, the process underlying chemical neurotransmission in the nervous system. He and his team use an array of structural and biophysical methods, including cryo-electron microscopy, optical microscopy, and cellular experimentation to explore the functional and dynamic aspects of neurotransmitter release. He is also known for developing methods and software for determining structures based on X-ray diffraction, cryo-electron microscopy, and solution NMR data.
Greenstone Biosciences announces that it will be making available its collection of healthy human iPS cell lines and lines with pathogenic variants for distribution! Greenstone Biosciences is the world’s largest biobank with collection of over 2000 iPS lines for human donors. Please contact us at info@greenstonebio.com for cell line inquiries.
Greenstone Biosciences co-founder Joseph C. Wu and BOD Lip-Bu Tan are honored and excited to welcome Brian Kobilka, Professor of Molecular & Cellular Physiology at Stanford, Nobel Laureate, to our Scientific Advisory Board! We look forward to his deep expertise in biochemistry and pharmacology to enhance our target-drug discovery efforts.
Greenstone Biosciences co-founder Joseph C. Wu and BOD Lip-Bu Tan are honored and excited to welcome Brian Kobilka, Professor of Molecular & Cellular Physiology at Stanford, Nobel Laureate, to our Scientific Advisory Board! We look forward to his deep expertise in biochemistry and pharmacology to enhance our target-drug discovery efforts.
Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health.
Our co-founder Dr. Joseph C. Wu was recently interviewed in The New York Times on the use of CRISPR gene editing for studying heart diseases !
We are thrilled to announced our project iPScelz with Creative Medical Technology Holdings (Nasdaq: $CELZ) in creating a cutting edge iPSC platform!
Due to the pandemic the inauguration ceremony was delayed and took place in Washington, DC, on October 15, 2022. Dr. Wu is the Simon H. Stertzer Professor of Medicine and Radiology at Stanford and Director of the Stanford Cardiovascular Institute. He was elected for seminal contributions and pioneer breakthroughs in the areas of cardiovascular medicine and imaging.
New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among NAM’s membership is assured by its Articles of Organization, which stipulate that at least one-quarter of the membership is selected from fields outside the health professions — for example, from such fields as law, engineering, social sciences, and the humanities. The newly elected members bring NAM’s total membership to more than 2,200 and the number of international members to approximately 180.
Founded in 1970 as the Institute of Medicine (IOM), the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. Operating under the 1863 Congressional charter of the National Academy of Sciences, the National Academies are private, nonprofit institutions that work outside of government to provide objective advice on matters of science, technology, and health.
Congratulations, Dr. Wu!